Gao, H., Li, W., Wu, Z., Dong, J., Cao, Y., Zhao, Y., Chen, Q., Ma, S., Ouyang, J., Ye, J., Yang, H., Zhang, Y., Zhang, Y., Zhang, G., Lin, Y., Lin, Y., Ye, G., Jiang, Z., Wang, K. (2025). De-escalated neoadjuvant taxane plus trastuzumab and pertuzumab with or without carboplatin in HER2-positive early breast cancer (neoCARHP): A multicentre, open-label, randomised, phase 3 trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba500